Insight Molecular Diagnostics Inc.
IMDXDrugs in Pipeline
7
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 2 past
No catalysts found.
99mTc-MIP-1404 Injection
Prostate Cancer
Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free
Dry Eye
UltratraceTM Iobenguane I 131 Imaging
Neuroblastoma
Iodofiltic acid I 123
Acute Coronary Syndrome
Ultratrace Iobenguane (MIBG) I 131
Pheochromocytoma
NeuVax vaccine
Breast Cancer
Drug: 99mTc-MIP-1404
Prostate Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
99mTc-MIP-1404 Injection | Phase 3 | Prostate Cancer | - | - |
Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free | Phase 3 | Dry Eye | - | - |
UltratraceTM Iobenguane I 131 Imaging | Phase 2 | Neuroblastoma | - | - |
Iodofiltic acid I 123 | Phase 2 | Acute Coronary Syndrome | - | - |
Ultratrace Iobenguane (MIBG) I 131 | Phase 2 | Pheochromocytoma | - | - |
NeuVax vaccine | Phase 2 | Breast Cancer | - | - |
Drug: 99mTc-MIP-1404 | Phase 2 | Prostate Cancer | - | - |